Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy

Diğer sürümleri göster (1)

Amodiaquine is effective for the treatment of Plasmodium vivax malaria, but there is little information on the pharmacokinetic and pharmacodynamic properties of amodiaquine in pregnant women with malaria. This study evaluated the population pharmacokinetic and pharmacodynamic properties of amodiaqui...

Detaylı Bibliyografya
Asıl Yazarlar:	Tarning, J, Chotsiri, P, Jullien, V, Rijken, M, Bergstrand, M, Cammas, M, McGready, R, Singhasivanon, P, Day, N, White, N, Nosten, F, Lindegardha, N
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	American Society for Microbiology 2012

Benzer Materyaller

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria.
Yazar:: Rijken, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria
Yazar:: Rijken, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Cardiovascular concentration-effect relationships of amodiaquine and its metabolite desethylamodiaquine: clinical and pre-clinical studies
Yazar:: Chotsiri, P, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria
Yazar:: Thomas A. Anyorigiya, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

High-throughput quantitation method for amodiaquine and desethylamodiaquine in plasma using supported liquid extraction technology
Yazar:: Kaewkhao, K, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Correction to: Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malaria
Yazar:: Thomas A. Anyorigiya, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.
Yazar:: Scarsi, K, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Population pharmacokinetics of the antimalarial amodiaquine: A pooled analysis to optimize dosing
Yazar:: Ali, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border
Yazar:: Kloprogge, F, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia
Yazar:: Lohy Das, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

POPULATION PHARMACOKINETICS OF ANTIMALARIAL DRUGS IN THE TREATMENT OF PREGNANT WOMEN WITH UNCOMPLICATED MALARIA
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria.
Yazar:: Lee, S, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Pharmacokinetics of intravenous amodiaquine.
Yazar:: White, N, ve diğerleri
Baskı/Yayın Bilgisi: (1987)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
Yazar:: Rijken, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
Yazar:: Kloprogge, F, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.
Yazar:: Mcgready, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: A population-based study
Yazar:: McGready, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.
Yazar:: Krishna, S, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
Yazar:: McGready, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Yazar:: Gilder, M, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
Yazar:: Adam, I, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
Yazar:: Das, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

POPULATION PHARMACOKINETICS OF ARTESUNATE AND AMODIAQUINE IN AFRICAN CHILDREN
Yazar:: Stepniewska, K, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Population pharmacokinetics of artesunate and amodiaquine in African children.
Yazar:: Stepniewska, K, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
Yazar:: Tarning, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Pharmacokinetic considerations in seasonal malaria chemoprevention
Yazar:: Chotsiri, P, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand.
Yazar:: Rijken, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
Yazar:: White, N, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
Yazar:: Ezzet, F, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
Yazar:: Kloprogge, F, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
Yazar:: Mwesigwa, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.
Yazar:: Mcgready, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
Yazar:: Jesmin Permala Lohy Das, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)